(Nanolyze) — San Francisco, Calif.-based Emerald Therapeutics unveiled its Emerald Cloud Laboratory in 2010. The ECL is a state-of-the-art life sciences laboratory that scientists can remotely access via the Internet, where automated robotics conduct experiments exactly as specified by the user. This “lab in the cloud” is a 15,000 square foot space that contains over $3 million in lab equipment that can now be used by anyone with an Internet connection and a credit card. The data from any experiments run in the ECL, as well as the rights to any material sent to the ECL or created using the ECL, belong to the user.
Emerald Therapeutics has taken in $34 million in funding so far from the likes of Peter Thiel and Max Levchin. The ECL has a number of key value propositions to offer the scientific community. The first is the lower cost of experiments and the accessibility that will eliminate the barriers to entry for many startups. The second is the predictability of experiments. Since the entire testing process is conducted by robots, there is no element of human error introduced into the experiments. The third is the aggregated knowledge that will accumulate with all the experiments being stored in the cloud. One can imagine how useful it would be to “share experiments” with others who are working on the same type of projects.Tags: Emerald Cloud Laboratory, Emerald Therapeutics, Max Levchin, Peter Thiel